1      0

2021 ISPE Aseptic Conference

VL21CEMAR1/SES105 - Revision of EU GMPs Annex 1: What Impacts Can We Expect as an Industry?


Mar 16, 2021 9:00am ‐ Mar 16, 2021 10:00am


Description

Revision of EU GMPs Annex 1: What Impacts Can We Expect as an Industry? | 2020 saw the commenting of the draft Annex 1, which included many changes to the 2017 version. In this session, we will cover the commenting process both from the ISPE and the PHSS perspective. Selected topics will be discussed in detail. Based on the outcome of the session with regulators from the 2020 ISPE Annual Meeting, we will give an outlook on the implementation of the final guidance issued by EMA.

Session Leader(s):

  • Jörg Zimmermann, Vice President, Vetter Development Service, External Affairs, Vetter Pharma-Fertigung GmbH & Co.

Speaker(s):

You must be logged in and own this session in order to post comments.